Platelet Transfusion Therapy

被引：30

作者：

Thiagarajan, Perumal ^{[1
,2
]}

Afshar-Kharghan, Vahid ^{[3
]}

机构：

[1] Baylor Coll Med, Michael E DeBakey Vet Affairs Med Ctr, Dept Pathol, Houston, TX 77030 USA

[2] Baylor Coll Med, Michael E DeBakey Vet Affairs Med Ctr, Dept Med, Houston, TX 77030 USA

[3] MD Anderson Canc Ctr, Sect Benign Hematol, Houston, TX 77030 USA

来源：

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2013年 / 27卷 / 03期

关键词：

Platelet transfusion; Alloimmunization; Transfusion triggers; Pathogen reduction; PATHOGEN INACTIVATION; CROSS-MATCH; APHERESIS PLATELETS; BLEEDING DIATHESIS; IN-VITRO; PHOSPHATIDYLSERINE; INCREMENTS; ALLOIMMUNIZATION; THROMBOCYTOPENIA; PERMEABILITY;

D O I：

10.1016/j.hoc.2013.03.004

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Platelet transfusion therapy has become an integral part of the treatment of patients with hematological and solid tumor malignancy receiving chemotherapy. Since its introduction almost 60 years ago, several advances and refinements have been introduced in the collection, storage, and administration to improve the safety and efficacy of platelet transfusion. This review summarizes the current practice and clinical approach to patients with thrombocytopenia. Existing evidence-based guidelines for appropriate platelet transfusion is reviewed.

引用

页码：629 / +

页数：16

共 50 条

[21] Platelet transfusion therapy: hot topics in 2021
Rebulla, Paolo
ANNALS OF BLOOD, 2022, 7
[22] Platelet Transfusion Refractoriness
Lubis, Anna Mira
Baskoro, Muhammad Orri
Yasmin, Amirah
PLASMATOLOGY, 2024, 18
[23] Guidance on Platelet Transfusion for Patients With Hypoproliferative Thrombocytopenia
Nahirniak, Susan
Slichter, Sherrill J.
Tanael, Susano
Rebulla, Paolo
Pavenski, Katerina
Vassallo, Ralph f
Fung, Mark
Duquesnoy, Rene
Saw, Chee-Loong
Stanworth, Simon
Tinmouth, Alan
Hume, Heather
Ponnampalam, Arjuna
Moltzan, Catherine
Berry, Brian
Shehata, Nadine
TRANSFUSION MEDICINE REVIEWS, 2015, 29 (01) : 3 - 13
[24] Platelet transfusion refractoriness due to HLA alloimmunization: Evolving paradigms in mechanisms and management
Panch, Sandhya R.
Guo, Li
Vassallo, Ralph
BLOOD REVIEWS, 2023, 62
[25] Platelet transfusion and respecting patient D type
Cid, Joan
Yazer, Mark H.
Lozano, Miguel
CURRENT OPINION IN HEMATOLOGY, 2015, 22 (06) : 540 - 546
[26] Related donor platelet transfusion improves platelet transfusion refractoriness in hematological patients
Zhang, Jing-Cheng
Ni, Li-Hong
Tu, Yan
Hu, Hui-Xian
FRONTIERS IN MEDICINE, 2023, 10
[27] The use of a potential novel tool in virtual crossmatching for platelet transfusion in platelet refractoriness
Bub, C. B.
Goncalez, A. C.
Barjas-Castro, M. L.
Sousa, L. C. D. M.
do Monte, S. J. H.
Castro, V.
VOX SANGUINIS, 2016, 110 (01) : 70 - 78
[28] Pathogen reduction with amotosalen/UVA reduces platelet refractoriness in a dog platelet transfusion model
Slichter, Sherrill J.
Bailey, S. Lawrence
Gettinger, Irena
Pellham, Esther
Christoffel, Todd
Castro, Grace
Green, Jennifer M.
Stassinopoulos, Adonis
VOX SANGUINIS, 2019, 114 (06) : 595 - 604
[29] Platelet-bound immunoglobulins before and after platelet transfusion:: measurement of in vivo binding
Levin, MD
de Vries, W
de Veld, J
Doekharan, D
van der Holt, B
van't Veer, MB
BRITISH JOURNAL OF HAEMATOLOGY, 1999, 104 (02) : 397 - 402
[30] Platelet transfusion improves clot formation and platelet function in severely thrombocytopenic haematology patients
Karlstrom, Cecilia
Gryfelt, Gunilla
Schmied, Laurent
Meinke, Stephan
Hoglund, Petter
BRITISH JOURNAL OF HAEMATOLOGY, 2022, 196 (01) : 224 - 233

← 1 2 3 4 5 →